USE OF PROSTAGLANDIN E1 (PGE1) AND MISOPROSTOL FOR TREATING CHRONIC MYELOGENOUS/MYELOID LEUKEMIA (CML)
    1.
    发明申请
    USE OF PROSTAGLANDIN E1 (PGE1) AND MISOPROSTOL FOR TREATING CHRONIC MYELOGENOUS/MYELOID LEUKEMIA (CML) 审中-公开
    PROSTAGLANDIN E1(PGE1)和MISOPROSTOL用于治疗慢性髓性白血病/ MYELOID LEUKEMIA(CML)的应用

    公开(公告)号:US20150342961A1

    公开(公告)日:2015-12-03

    申请号:US14729937

    申请日:2015-06-03

    Applicant: Hai-Hui Xue

    Inventor: Hai-Hui Xue

    CPC classification number: A61K31/5575 A61K31/506

    Abstract: Disclosed are methods and compositions for treating a patient having chronic myelogenous/myeloid leukemia (CML). The methods utilize and the compositions include prostaglandin E1 (PGE1) or Misoprotol.

    Abstract translation: 公开了用于治疗患有慢性骨髓/骨髓性白血病(CML)的患者的方法和组合物。 该方法使用并且组合物包括前列腺素E1(PGE1)或米索普罗。

Patent Agency Ranking